


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-3.71%
-1.67%
+2.74%
+1.59%
-0.40%
AZN
Astrazeneca
$93.84
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
AZN Price Performance
$89.83 (+4.46%)
$84.83 (+10.62%)
$79.54 (+17.98%)
$69.59 (+34.85%)
AZN has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

AZN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
AZN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
AZN Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
PFE
25.04
-0.93%
MRK
107.93
-1.17%
NVS
142.03
+0.15%
SNY
46.83
-1.62%
HCM
14.97
+0.27%
CDZIP
Cadiz Inc.
19.60
+0.01%
AZN
Astrazeneca
93.84
+0.20%
ESI
Element Solutions
28.25
-0.18%
ANTX
AN2 Therapeutics
1.23
+7.89%
ACHC
Acadia Healthcare
12.99
-1.81%
What is AZN current stock price?
What are AZN stock strengths?
What is AZN Risk Level?
What is AZN market cap and volume?
What is AZN current Stock IQ?
Should I buy AZN stock right now?
Is AZN a Strong Buy right now?
What does a 'Strong Buy' rating mean for AZN?
What does a 'Strong Sell' rating mean for AZN?
What factors influence AZN's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-3.71%
-1.67%
+2.74%
+1.59%
-0.40%
AZN
Astrazeneca
Current Price
$93.84
AZN Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
Linked to AZN
PFE
25.04
-0.93%
MRK
107.93
-1.17%
NVS
142.03
+0.15%
SNY
46.83
-1.62%
HCM
14.97
+0.27%
Recently Viewed
CDZIP
Cadiz Inc.
19.60
+0.01%
AZN
Astrazeneca
93.84
+0.20%
ESI
Element Solutions
28.25
-0.18%
ANTX
AN2 Therapeutics
1.23
+7.89%
ACHC
Acadia Healthcare
12.99
-1.81%

AZN Price Performance
$89.83 (+4.46%)
$84.83 (+10.62%)
$79.54 (+17.98%)
$69.59 (+34.85%)
AZN Analysts Opinion
AZN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
AZN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
AZN Street Sentiment is extremely bullish and have positive views on the near-term outlook
AZN has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Investors losing confidence

Average key support and resistance price levels
AZN Latest Analysis
Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know. Astrazeneca (AZN) concluded the recent trading session at $94.01 signifying a -1.21% move from its prior days close.
Thu Jan 8, 2026
Heres Why Astrazeneca (AZN) is a Strong Momentum Stock. The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why you should take advantage.
Thu Jan 8, 2026
AstraZenecas Self-Injectable Lupus Drug Shines In Late-Stage Trial. On Tuesday ) released complete results from the Phase 3 TULIP-SC trial of a subcutaneous (SC) administration of anifrolumab versus placebo in participants aged 18 to 70 years with moderately to severely active autoantibody-positive .Topline data was shared .Subcutaneous (SC) administration of Saphnelo (anifrolumab) showed a statistically significant and clinically meaningful reduction in disease activity compared to placebo.Also
Tue Jan 6, 2026
AMD and its Partners Share their Vision for AI Everywhere for Everyone at CES 2026. AMD provided an early look at its Helios rack-scale platform the blueprint for yotta-scale AI infrastructure built on AMD Instinct MI455X GPUs and AMD EPYC Venice CPUs designed for advanced AI workloadsAMD expanded its AI portfolio with the introduction of the AMD Instinct MI440X GPU for enterprise deployments and previewed the next-generation Instinct MI500 Series GPUsLaunched new AMD Ryzen AI platforms for AI P
Tue Jan 6, 2026
Top Stock Reports for Berkshire Hathaway AstraZeneca & Intel. Berkshire Hathaways shares have edged past its industry backed by insurance growth rising float strong cash and expanding investments including Japan.
Tue Dec 30, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.